SEC Form 4 · accession 0001562180-18-002202
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John H Weiland
Director
Period of report
May 1, 2018
Accepted (ET)
May 3, 2018 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 1, 2018 | A | 1,824 | $0.00 | A | 45,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
- F2Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.